Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

NEWS

Dual therapy with Erenumab and onabotulinumtoxinA: no synergistic effect in chronic migraine -A retrospective cohort study.

PUBLISHED

27 January 2023

RECENT POSTS

Jerin Mathew, PhD, Receives the 2025 IASP Early Career Research Grant

12 December 2024

IASP Formally Endorses the ENhancing TRUST in Pain Evidence (ENTRUST-PE) Framework 

05 December 2024

Allan Basbaum, IASP Honorary Member, Receives the Ralph W. Gerard Prize in Neuroscience

26 September 2024

Dr. Andrew Rice Becomes 20th President of the International Association for the Study of Pain

09 August 2024

To assess whether dual therapy with erenumab and onabotulinumtoxinA (BoNTA) was more effective than erenumab alone in chronic migraine.

Posted in
Share this